Concepedia

Michael K. Wong

MK

Statistics

Publications

71

Citations

5.3K

H-Index

36

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Southern California

Duke Medical Center

University of California, San Francisco

UPMC Hillman Cancer Center

Michael K. Wong is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1984–2025

71

Publications

71

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan et al. · Science · 2021 · 804 citations · Full text

, , +28

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi et al. · Nature Medicine · 2018 · 797 citations · Full text

, , +5

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton et al. · Nature · 2022 · 312 citations · Full text

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

Rodabe N. Amaria, Peter A. Prieto, Michael T. Tetzlaff et al. · The Lancet Oncology · 2018 · 285 citations

, , +11

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Daniel H. Johnson, Chrystia M. Zobniw, Van Anh Trinh et al. · Journal for ImmunoTherapy of Cancer · 2018 · 185 citations · Full text

1–5 of 71